Greater Glasgow and Clyde Medicines

GGC guidance on the Treatment of Vitamin B12 Deficiency in Adults is available 

Updates from the MHRA for the second quarter of 2019 Drug Safety Update includes:

Staff are asked to be aware of the following correction to the Initial Management of Neutropenic Sepsis in Adu...

New Adult NHSGGC Guidelines now available on StaffNet

The Adult Therapeutics Handbook content has now been updated. Several sections have had minor content updates. Other changes include:

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary

Targinact^® (oxycodone with naloxone) prolonged release tablets are not recommended for use within NHS Scotland for the treatment of severe pain which can only be managed with opioid analgesics. Despite this, use in selected clinical areas o...

Reports of adverse events associated with fluoroquinolone use prompted a recent EU safety review....

Key messages In January 2019, the Faculty of Sexual and Reproductive Healthcare (FSRH) published updated clinical guidan...

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary